K(

Kevin (penghui) Chen

Founding Partner at Biotrack Capital

Shanghai

Investor
VC

Invests in

Stages:

Seed
Pre-seed

Locations:

Shanghai

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Investment
Healthcare
Chemical
Consumer

Education

Lists including Kevin (Penghui)

AM
AT
AS
AR

All Seed Investors

19691 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

Investments

Yizhun Intelligent

Series C

Total Funding:

SeekGene

Series A

Total Funding: $15M

Exegenesis Bio

Series B

Total Funding:

CF PharmTech

Series F

Total Funding: $51M

Work Experience

Biotrack Capital

2017

  • Founding Partner

    2017

    Healthcare dedicated VC fund

SC
Sequoia Capital China

2014 - 2017

  • Partner

    2014 - 2017

China Everbright Limited, Healthcare fund

2011 - 2014

  • Head & Managing Director

    2011 - 2014

    A newly raised fund focusing on investment in China healthcare industry

ShangPharma Corporation (NYSE SHP)

2007 - 2011

  • President and COO

    2011 - 2011

    One of the largest CRO companies in China providing R&D services to global and local pharmaceutical and biotech companies

  • COO & CFO

    2007 - 2010

    One of the largest CRO companies in China providing R&D services to global and local pharmaceutical and biotech companies

D
DuPont

2003 - 2006

  • Senior Manager of Corporate Investment and Business Development

    2003 - 2006

    Leading Global Chemical Company. Business Development and M&A

LP
Ligand Pharmaceuticals

1998 - 2001

  • Research Scientist

    1998 - 2001

    Biotechnology company